Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Shelter Pharma Ltd
Your Vote -
Buy
40.00%
Hold
20.00%
Sell
40.00%
40.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Shelter Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended November 17, 2025
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended November 15, 2025
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, November 17, 2025 Considered And Appr
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Allotment
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, November 15, 2025 Considered And Ap
-
Shelter Pharma - Intimation With Regards To 'Shelter Pharma' Received ISO 22000:2018 Certification
-
Shelter Pharma - Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Re
-
Shelter Pharma - Outcome Of The Board Meeting Held On Monday, 10 November 2025 And Submission Of The Unaudited Financial Resu
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 10 November 2025 And Submission Of Th
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On 10Th November, 2025
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended October 16, 2025
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Shelter Pharma - Board Meeting Outcome for 8,61,000 Equity Shares Allotted Pursuant To Conversion Of Warrants\r\n
Key fundamentals
Evaluate the intrinsic value of Shelter Pharma Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 43.7647 | 36.3931 | 16.2947 | 8.9366 | 7.1865 |
| Liabilities | 43.7647 | 36.3931 | 16.2947 | 8.9366 | 7.1865 |
| Equity | 11.5598 | 11.5598 | 7.7438 | 0.4839 | 0.4839 |
| Gross Profit | 10.0677 | 8.5714 | 8.0574 | 2.9223 | 0.1801 |
| Net Profit | 7.2374 | 6.2002 | 5.7833 | 1.8569 | 0.0509 |
| Cash From Operating Activities | 5.4822 | -1.8502 | 0.0033 | 0 | 0 |
| NPM(%) | 14.28 | 15.49 | 15.99 | 6.17 | 0.22 |
| Revenue | 50.6602 | 40.0229 | 36.1527 | 30.0554 | 22.4834 |
| Expenses | 40.5925 | 31.4515 | 28.0953 | 27.1331 | 22.3032 |
| ROE(%) | 13.93 | 11.93 | 11.13 | 3.57 | 0.09 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shelter Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 744.00 | -0.27 | 0.00 | 20.12 | 301.39 | 0.68 |
| Lotus Eye Hospital and Institute Ltd | 113.60 | -4.98 | 348.69 | 73.31 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 18.68 | -3.51 | 0.00 | 152.21 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 639.60 | -3.63 | 0.00 | 69.13 | -604.77 | 0.00 |
Company Info
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
Read More
Parent Organisation
Shelter Pharma Ltd.
Founded
12/10/2007
Managing Director
Mr.Mustaqim Nisarahmed Sabugar
NSE Symbol
FAQ
The current price of Shelter Pharma Ltd is
The 52-week high for Shelter Pharma Ltd is
The market capitalization of Shelter Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shelter Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shelter Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shelter Pharma Ltd shares.
The CEO of Shelter Pharma Ltd is Mr.Mustaqim Nisarahmed Sabugar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
